ADIPOQ and breast carcinoma: Our data suggest that adiponectin-triggered increase of CASP1 expression might be another molecular mechanism underlying the antitumoural effect of this adipocytokine, which is present in mammary epithelial cells, but has been lost in MCF-7 breast cancer cells.